Moreover, enhanced cytotoxic CD8+ T cell frequencies within the tumor microenvironment (TME) are correlated with favorable outcomes in breast (4, 5), colorectal (6), melanoma (7), ovarian (8), and pancreatic cancers (9). This evidence concerns the gene CD8A and neoplasm.